Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
The disposition and metabolism of pentamethylmelamine (PMM) and hexamethylmelamine (HMM) were studied in the rabbit, and the disposition of PMM was studied in humans. Parent compound and metabolites were identified by thin-layer chromatography, gas chromatography, and gas chromatography/mass spectrometry analyses. Plasma elimination in both species following i.v. administration of each drug was best described by a two-compartment open model. Both compounds were extensively demethylated with less than 1% of the total dose administered recovered in the urine over 24 hr. The areas under the plasma time-concentration curves of PMM and HMM following p.o. administration to rabbits were 5 and 25% of the areas following i.v. administration. Gastrointestinal absorption was rapid and efficient with 75 to 89% of drug equivalents recoverable in the urine after p.o. administration of [ring-14C]PMM or [ring-14C]HMM to rabbits. Reduced bioavailability of PMM and HMM p.o. appears to be a consequence of rapid metabolism presumably in the liver.
D006585:Altretamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism*; D000818:Animals; D001682:Biological Availability; D004341:Drug Evaluation; D006801:Humans; D007408:Intestinal Absorption; D008099:Liver / Q000378:metabolism; D008297:Male; D009369:Neoplasms / Q000378:metabolism; D011817:Rabbits; D013997:Time Factors; D014227:Triazines / Q000378:metabolism*
D014227:Triazines; D006585:Altretamine; C022048:pentamethylmelamine